These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37655344)

  • 1. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
    Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
    Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
    Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
    Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the presence of
    Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
    Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
    Liu W; Zhang R; Shu R; Yu J; Li H; Long H; Jin S; Li S; Hu Q; Yao F; Zhou C; Huang Q; Hu X; Chen M; Hu W; Wang Q; Fang S; Wu Q
    Biomed Res Int; 2020; 2020():7828392. PubMed ID: 32083132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers.
    Fang CY; Chen JS; Hsu BM; Hussain B; Rathod J; Lee KH
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.
    Ye Q; Sun S; Deng J; Chen X; Zhang J; Lin S; Du H; Gao J; Zou X; Lin X; Cai Y; Lu Z
    Sci Rep; 2023 Nov; 13(1):20253. PubMed ID: 37985845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
    Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
    Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform.
    Wei PL; Hung CS; Kao YW; Lin YC; Lee CY; Chang TH; Shia BC; Lin JC
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1).
    Ren Y; Ma Q; Zeng X; Huang C; Tan S; Fu X; Zheng C; You F; Li X
    BMC Microbiol; 2024 Apr; 24(1):132. PubMed ID: 38643115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.